Skip to main content
Clinical Trials/NCT04228367
NCT04228367CompletedNot Applicable

JuggerStitch™ for Meniscal Repair Post Market Clinical Follow-up Study

Zimmer Biomet17 sites in 4 countries103 target enrollmentStarted: September 25, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
103
Locations
17
Primary Endpoint
Clinical Success

Study Overview

Brief Summary

This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).

Detailed Description

This study is a post-market follow-up study to fulfil the post-market surveillance obligations according to Medical Device Directive and MEDDEV 2.12/2 and the Medical Devices Regulation (MDR 2017/745). The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (IFU).

The objectives of the study are to calculate the overall clinical success rate and the performance, and confirm the safety of the JuggerStitch Meniscal Repair Device. The primary endpoint of this study is defined by the absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at one year.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Subject qualifies for meniscal repair based on the physical exam and medical history and meets the approved indications for use of the study product;
  • •Older than 18 years and skeletally mature;
  • •Willing and able to comply with the study procedures;
  • •Subject is capable of understanding the doctor's explanations, following his instructions and is able to participate in the follow-up program;
  • •Subject is able to read and understand the informed consent form (ICF) and has voluntarily provided written informed consent.

Exclusion Criteria

  • •Meniscal tears in the avascular zone of meniscus;
  • •Meniscal tears not suitable for repair because of the degree of damage(marked irregularity and complex tearing) to the meniscus body including degenerative, radial, horizontal cleavage and flap tears;
  • •Presence of active infection;
  • •If female, subject is pregnant;
  • •Subject is vulnerable (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant);
  • •The subject is unwilling or unable to give consent or to comply with the follow-up program;
  • •Subject meets any contraindications of the appropriate Instruction for Use.

Arms & Interventions

Meniscal repair

Experimental

Patients in need of meniscal repair

Intervention: JuggerStitch Meniscal Repair Device (Device)

Outcomes

Primary Outcomes

Clinical Success

Time Frame: From the date of surgery through the participant's last available follow-up; minimum follow-up of 1 year and mean follow-up of 3.2 years

The absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at 1 year. Clinical success was defined as the absence of reoperation of the index knee due to a meniscal tear from the date of surgery through the participant's last available follow-up. All participants included in the analysis had at least 1 year of follow-up, and follow-up beyond 1 year was included when available.

Clinical Success

Time Frame: 1 year

The absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at one year.

Secondary Outcomes

  • International Knee Documentation Committee Subjective Knee Evaluation Form Score(Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively)
  • Number of Adverse Events(From the date of surgery through the participant's last available follow-up; minimum follow-up of 1 year and mean follow-up of 3.2 years)
  • Lysholm Knee Scoring Scale Score(Pre-operatively, 6 weeks, 6 months and 1 year post-surgery)
  • Tegner Activity Scale Score(Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively)
  • Number of Participants by Joint Line Tenderness Test Result(Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively)
  • Number of Participants by McMurray Test Result(Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively)
  • Monitoring of Adverse Events to confirm safety of the meniscal repair device(1 year)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (17)

Loading locations...

Similar Trials